{"id":"W3007159492","doi":"10.1093/jcag/gwz047.232","title":"A233 VEDOLIZUMAB FOR STEROID & INFLIXIMAB-REFRACTORY ICI-COLITIS","year":2020,"lang":"en","type":"article","venue":"Journal of the Canadian Association of Gastroenterology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Infliximab; Vedolizumab; Colitis; Internal medicine; Gastroenterology; Ipilimumab; Ulcerative colitis; Adverse effect; Discontinuation; Nivolumab; Surgery; Cancer; Tumor necrosis factor alpha; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001982065,0.0002826917,0.0005780455,0.0002579742,0.0004345895,0.0002594574,0.0002343853,0.0004947157,0.003868553],"category_scores_gemma":[0.0002456082,0.00007752828,0.0003814966,0.0001494614,0.0002422952,0.0001529063,0.0001335897,0.0006303372,0.0005643753],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003399594,"about_ca_system_score_gemma":0.0001996061,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005224332,"about_ca_topic_score_gemma":0.00111026,"domain_scores_codex":[0.9998811,0.00002928137,0.00001783527,0.0000221473,0.00001396428,0.00003553539],"domain_scores_gemma":[0.9998586,0.00003209465,0.0000274694,0.000007297446,0.000008162167,0.000066437],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"case_report","study_design_scores_codex":[0.1044102,0.0111239,0.07794561,0.002392308,0.00125716,0.09170528,0.0002293592,0.001514897,0.1192348,0.001890256,0.02382703,0.5644692],"study_design_scores_gemma":[0.05855279,0.1504476,0.2739366,0.0009842863,0.002613745,0.2765941,0.0005136364,0.007358539,0.06136996,0.002276362,0.1651729,0.0001795822],"study_design_candidate":"case_report","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.961432,0.0210055,0.001237042,0.003097995,0.0004870183,0.0004186326,0.0004935166,0.00009276533,0.01173552],"genre_scores_gemma":[0.9931236,0.00224833,0.0006263704,0.0008702467,0.0001928829,0.00009025949,0.0003145466,0.000006586,0.002527119],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003868553,"threshold_uncertainty_score":0.0129416,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01977166702307934,"score_gpt":0.2553049526102673,"score_spread":0.235533285587188,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}